Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center ( Site 0135), Burbank
City of Hope Comprehensive Cancer Center ( Site 0191), Duarte
Bass Medical Group ( Site 0123), Walnut Creek

Renkami dalyviai2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT06890884

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

City of Hope, Duarte
University of California, Los Angeles (UCLA) - Medical Center, Los Angeles
University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, San Francisco

Renkami dalyviai1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT07226843

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

City of Hope, Duarte

Renkami dalyviai1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT07101328

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Children's Hospital Los Angeles ( Site 1006), Los Angeles

Renkami dalyviai1/2 fazė

6 Months – 25 Years · Visoms lytims · Atnaujinta 2026-09-17 · NCT06395103

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

City of Hope Medical Center, Duarte
University of California San Diego Medical Center, Moores Cancer Center, La Jolla

Renkami dalyviai1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-15 · NCT07195916

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

Community Cancer Institute (CCI), Clovis
Providence Medical Foundation, Fullerton
Los Angeles Cancer Network, Glendale
ir dar 4

Renkami dalyviai2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-11 · NCT06806033

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

City of Hope Comprehensive Cancer Center, Duarte
University of California Davis Comprehensive Cancer Center, Sacramento

Renkami dalyviai1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-10 · NCT05272384

Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

City of Hope Medical Center, Duarte

Renkami dalyviai2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-28 · NCT07365306

A Study of ARC-02 in B-cell NHL

Start Cala, Los Angeles

Renkami dalyviai1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-26 · NCT07691606

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

University of California-Irvine Medical Center, Irvine
Cedars-Sinai Medical Center, Los Angeles
University of California, Los Angeles (UCLA) Medical Center, Los Angeles
ir dar 1

Renkami dalyviai1/2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-25 · NCT05826535

Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies

Cedars-Sinai Medical Center, Los Angeles

Renkami dalyviai1 fazė

Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-08-10 · NCT05887167

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

City of Hope, Duarte
Valkyrie Clinical Trials, Los Angeles

Renkami dalyviai1/2 fazė

Amžius nuo 13 iki 90 · Visoms lytims · Atnaujinta 2026-08-06 · NCT06533579

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

Stanford University, Stanford

Renkami dalyviaiStebimasis tyrimas

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-05 · NCT06116110

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Cedars-Sinai Medical Center, Los Angeles
University of California, Los Angeles (UCLA), Los Angeles
University of California, Irvine, Orange

Renkami dalyviai3 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-04 · NCT07188558

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

START Los Angele, Los Angeles

Renkami dalyviai1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-30 · NCT07424833

Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T Cells for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

University of California Davis Comprehensive Cancer Center, Sacramento

Renkami dalyviai1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-17 · NCT05052528

DALY II USA/ MB-CART2019.1 for DLBCL

UC San Diego Health, La Jolla
Stanford University, Stanford

Renkami dalyviai2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-13 · NCT04792489

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

City of Hope Comprehensive Cancer Center, Duarte

Renkami dalyviai1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-10 · NCT05077527

Loncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

City of Hope Medical Center, Duarte

Renkami dalyviai2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-10 · NCT05672251

Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

City of Hope Comprehensive Cancer Center, Duarte
University of California Davis Comprehensive Cancer Center, Sacramento

Renkami dalyviai1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-09 · NCT06015880

Odronextamab for the Treatment of Relapsed and Refractory Diffuse Large B-cell Lymphoma Before and After Chimeric Antigen Receptor T-cell Therapy

University of California Davis Comprehensive Cancer Center, Sacramento

Renkami dalyviai2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-08 · NCT06854159

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

City of Hope, Duarte
University of California, San Francisco, San Francisco

Renkami dalyviai1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-02 · NCT05131022

Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma

University of California Davis Comprehensive Cancer Center, Sacramento

Renkami dalyviai2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-30 · NCT06905509

Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

University of California, San Francisco, San Francisco

Renkami dalyviai1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-22 · NCT04545762

Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

City of Hope Medical Center, Duarte

Renkami dalyviai1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-20 · NCT06859008

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

City of Hope, Duarte
Los Angeles Cancer Network, Los Angeles
UCLA Medical Center of Hematology/Oncology, Los Angeles
ir dar 1

Renkami dalyviai1/2 fazė

Amžius nuo 12 iki 95 · Visoms lytims · Atnaujinta 2026-04-15 · NCT04329728

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

City of Hope, Duarte

Renkami dalyviai1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-03-20 · NCT04830137

Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
University of California Davis Comprehensive Cancer Center, Sacramento

Renkami dalyviai1/2 fazė

Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-03-10 · NCT05256641

Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma With Exposure to High-Risk Antibiotics Who Are Receiving Chimeric Antigen Receptor T Cells

City of Hope Medical Center, Duarte

Renkami dalyviai2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-03-05 · NCT07042438

Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma

City of Hope Medical Center, Duarte

Renkami dalyviai1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-23 · NCT05432635

Evaluation of Bridging Radiation Therapy Before CAR T-Cell Infusion for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma

City of Hope Medical Center, Duarte

Renkami dalyviaiAnkstyvoji 1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-04 · NCT05800405

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

UC Irvine Health Cancer Center-Newport, Costa Mesa
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
UCI Health Laguna Hills, Laguna Hills
ir dar 2

Renkami dalyviai2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-02 · NCT05633615

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

Tower Cancer Research Foundation, Beverly Hills
City of Hope Comprehensive Cancer Center, Duarte
City of Hope Seacliff, Huntington Beach
ir dar 7

Renkami dalyviai2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-10-20 · NCT05890352

A Study of NX-1607 in Adults With Advanced Malignancies

University of Southern California, Los Angeles
University of California, San Francisco, San Francisco

Renkami dalyviai1 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-09-09 · NCT05107674

Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.